5121-34-6

Basic information

• Product Name: Methyl 2-aMino-3-Methoxybenzoate
• Synonyms: Methyl 2-aMino-3-Methoxybenzoate;Benzoic acid, 2-aMino-3-Methoxy-, Methyl ester;Methyl 2-aMino-3-Methoxybenzoatec;2-Amino-3-methoxy-benzoic acid methyl ester;Methyl 3-methoxy-2-aminobenzoate;Methyl 3-methoxyanthranilate
• CAS NO: 5121-34-6
• Molecular Formula: C₉H₁₁NO₃
• Molecular Weight: 181.18854
• EINECS: 200-589-5
• Mol File: 5121-34-6.mol
• Article Data: 27

Chemical Properties

• Melting Point: 46.0 to 50.0 °C
• Boiling Point: 117°C/2mmHg(lit.)
• Flash Point: 133.4 °C
• Appearance: /
• Density: 1.179 g/cm³
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 2.13±0.10(Predicted)
• CAS DataBase Reference: Methyl 2-aMino-3-Methoxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-aMino-3-Methoxybenzoate(5121-34-6)
• EPA Substance Registry System: Methyl 2-aMino-3-Methoxybenzoate(5121-34-6)

Safety Data

• Hazardous Substances Data: 5121-34-6(Hazardous Substances Data)

Usage

General Description

Methyl 2-amino-3-methoxybenzoate is an organic compound with the molecular formula C9H11NO3. It is a derivative of benzoic acid and is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. This chemical is often employed as a building block in the production of various medicines, including pain relievers and anti-inflammatory drugs. Methyl 2-amino-3-methoxybenzoate is a white, crystalline solid that is sparingly soluble in water but more soluble in organic solvents. It is important to handle this chemical with care, as prolonged or repeated exposure to it may cause skin irritation and allergic reactions.

Upstream product

• 186581-53-3 diazomethane 
• 548-93-6 3-hydroxyanthranilic acid 
• 3177-80-8 2-amino-3-methoxybenzoic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 74-88-4 methyl iodide 
• 4920-80-3 3-methoxy-2-nitrobenzoic acid 
• 4771-47-5 3-chloro-2-nitro-benzoic acid 
• 602-00-6 3-hydroxy-2-nitrobenzoic acid 
• 67-56-1 methanol 
• 34954-65-9 3-methoxyisatoic anhydride 
• 5368-81-0 methyl 3-methoxybenzoate 
• 84575-27-9 7-methoxy-1H-indole-2,3-dione 
• 115378-20-6 3-methoxy-2-pivalamidobenzoic acid 
• 90-04-0 2-methoxy-phenylamine 

Downstream Products

• 873995-53-0 2-(2-amino-3-methoxyphenyl)propan-2-ol 
• 59425-26-2 2-Chloro-3-methoxybenzoic acid methyl ester 
• 58026-22-5 2-amino-5-chloro-3-methoxybenzoic acid 
• 864292-36-4 6-bromo-2,4-dichloro-8-methoxyquinazoline 
• 1415470-79-9 (2S,3R,4R,5S,6R)-2-(6-(4-ethylbenzyl)-7-chloro-2,3-dihydrobenzofuran-4-yl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1415470-82-4 (2S,3R,4R,5S,6R)-2-(8-chloro-7-(4-ethylbenzyl)chroman-5-yl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1415470-83-5 (2S,3R,4R,5S,6R)-2-(7-chloro-6-(4-ethoxybenzyl)-2,3-dihydrobenzofuran-4-yl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 697762-67-7 methyl 5-bromo-2-chloro-3-methoxybenzoate 
• 1415467-76-3 5-bromo-2-chloro-3-methoxybenzoic acid 

Relevant articles and documents

Discovery of GCC5694A: A potent and selective sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes

Sodium-dependent glucose co-transporter 2 (SGLT2) has emerged as a promising drug target for the treatment of type 2 diabetes, and recently, several SGLT2 inhibitors have been approved for clinical use. A series of molecules with a C-aryl glucoside scaffo

Evolution of N-Heterocycle-Substituted Iodoarenes (NHIAs) to Efficient Organocatalysts in Iodine(I/III)-Mediated Oxidative Transformations

The reactivity of ortho-functionalized N-heterocycle-substituted iodoarenes (NHIAs) as organocatalysts in iodine(I/III)-mediated oxidations was systematically investigated in the α-tosyloxylation of ketones as the model reaction. During a systematic catalyst evolution, it was found that NH-triazoles and benzoxazoles have the most significant positive influence on the reactivity of the central iodine atom. A further catalyst improvement which focused on the substitution pattern of the arene revealed a remarkable ortho-effect. By introduction of an o-OMe group we were able to generate a novel NHIA with a so far unseen catalytic efficiency. This new catalyst is not only easy to synthesize but also enabled the α-tosyloxylation of carbonyl compounds at the lowest reported catalyst loading of only 1 mol%. Finally, the performance of this iodine(I) catalyst was successfully demonstrated in intramolecular oxidative couplings of biphenyls and oxidative rearrangements. (Figure presented.).

BENZOXABOROLE COMPOUNDS AND FORMULATIONS THEREOF

A benzoxaborole formulation composition including a benzoxaborole, a non-ionic surfactant, or a non-ionic and ionic surfactant mixture, and a carrier is described herein. At least one of the non-ionic surfactant, the non-ionic and ionic surfactant mixture